2-Methyl-4-amino-6-(n-butyl)amino-s-triazin | 27418-94-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三嗪类
• 英文名称: 2-Methyl-4-amino-6-(n-butyl)amino-s-triazin
• 英文别名: N-butyl-6-methyl-[1,3,5]triazine-2,4-diamine；2-N-butyl-6-methyl-1,3,5-triazine-2,4-diamine
• CAS: 27418-94-6
• 化学式: C₈H₁₅N₅
• 分子量: 181.241
• InChiKey: FICAXONNIJXFPY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  76.7
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• Compositions and Methods for Treating Metabolic Disorders
  申请人：Elcelyx Therapeutics, Inc.

  公开号：US20140193498A1

  公开（公告）日：2014-07-10

  Compositions and methods for improving the pharmacokinetics and reducing the risk of adverse events resulting from biguanide compound administration are provided, comprising administering delayed release formulations of such compounds having a lag phase release.

  本发明提供了用于改善双胍类化合物的药代动力学并减少由其使用导致的不良事件风险的组合物和方法，包括给予延迟释放配方的这种化合物，其具有滞后释放阶段。
• METHODS FOR MODIFYING 1,3,5-TRIAZINE DERIVATIVES
  申请人：NISSAN CHEMICAL INDUSTRIES, LIMITED

  公开号：EP0882720A1

  公开（公告）日：1998-12-09

  A method for modifying 1,3,5-triazine derivatives characterized by reacting a 1,3,5-triazine derivative having at least one amino or monosubstituted amino group on any of the ring carbon atoms with an alcohol by heating in the presence of a metallic catalyst and hydrogen to thereby introduce an alkyl or alkenyl group into each amino or monosubstituted amino group; another method for modifying 1,3,5-triazine derivatives characterized by reacting a 1,3,5-triazine derivative having at least one amino or monosubstituted amino group on any of the ring carbon atoms with a dihydric alcohol by heating in the presence of a metallic catalyst and hydrogen to thereby introduce a hydroxylated alkyl group into each amino or monosubstituted amino group; and 1,3,5-triazine derivatives obtained by the methods. The various modified substituted 1,3,5-triazine derivatives thus produced are generally obtained as a mixture. These derivatives can be isolated as high-purity compounds by a general separation method for organic compounds, and the compounds are usable in the various applications mentioned in the specification. According to applications (for example, use as modifier additives, in particular a flame-retardant and a plasticizer for resins), the reaction mixture can be used as it is without being separated. Many of the substituted triazine derivatives obtained have been relatively difficult to synthesize or expensive. Since many of the derivatives are interesting with respect to their physical properties, e.g., solubility in water and in various organic solvents, high-temp. stability, melting point, boiling point, and basicity, they are thought to have a wider range of applications than conventional ones.

  一种改性 1，3，5-三嗪衍生物的方法，其特征在于在金属催化剂和氢的存在下，通过加热使任一环碳原子上具有至少一个氨基或单取代氨基的 1，3，5-三嗪衍生物与醇反应，从而在每个氨基或单取代氨基中引入一个烷基或烯基；另一种改性 1,3,5-三嗪衍生物的方法，其特征在于在金属催化剂和氢气存在下，使任一环碳原子上具有至少一个氨基或单取代氨基的 1,3,5-三嗪衍生物与二元醇反应，从而在每个氨基或单取代氨基中引入羟基烷基；以及通过上述方法获得的 1,3,5-三嗪衍生物。这样制得的各种改性取代的 1,3,5-三嗪衍生物通常以混合物的形式获得。这些衍生物可作为高纯度化合物通过有机化合物的一般分离方法分离出来，这些化合物可用于说明书中提到的各种应用中。根据用途（例如用作改性添加剂，特别是阻燃剂和树脂增塑剂），反应混合物可以不经分离直接使用。所获得的许多取代三嗪衍生物都比较难以合成或价格昂贵。由于许多衍生物在物理性质（如在水和各种有机溶剂中的溶解性、高温稳定性、熔点、沸点和碱性）方面都很有趣，因此它们被认为比传统的衍生物具有更广泛的用途。
• Biguanide compositions and methods of treating metabolic disorders
  申请人：Elcelyx Therapeutics, Inc.

  公开号：US10028923B2

  公开（公告）日：2018-07-24

  Provided herein are methods for treating certain conditions, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a biguanide or related heterocyclic compound, e.g., metformin. Also provided herein are biguanide or related heterocyclic compound compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.

  本文提供了通过施用包含双胍类或相关杂环化合物（如二甲双胍）的组合物来治疗某些疾病（包括糖尿病、肥胖症和其他代谢性疾病、失调或病症）的方法。本文还提供了双胍类或相关杂环化合物组合物及其用于本发明方法的制备方法。本文还提供了包含二甲双胍及其盐类的组合物和使用方法。
• BIGUANIDE COMPOSITIONS AND METHODS OF TREATING METABOLIC DISORDERS
  申请人：Anji Pharma (US) LLC

  公开号：EP2800561B1

  公开（公告）日：2020-08-19
• Biguanide Compositions and Methods of Treating Metabolic Disorders
  申请人：Baron Alain D.

  公开号：US20130095140A1

  公开（公告）日：2013-04-18

  Provided herein are methods for treating certain conditions, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a biguanide or related heterocyclic compound, e.g., metformin. Also provided herein are biguanide or related heterocyclic compound compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.